UCL clinician scientist honored with lifetime achievement award

The award was presented to Professor Lee at the recent 21st BTOG Annual Conference 2023 in Belfast, Northern Ireland. The BTOG awarding committee commented that Professor Lee’s ‘dedication to, and tenacity in [his] work is truly inspiring.’

BTOG is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK and Ireland. The group fosters the development of research, develops educational programs for healthcare professionals and represents the needs of patients to improve the outcomes of lung cancer.

Throughout his career, Professor Lee has focused on advancing our understanding and treatment of lung cancer. He has designed and led numerous lung cancer trials over more than two decades which have changed practice and improved treatment outcomes for lung cancer patients. His latest trials examine the role of atezolizumab, an immunotherapy drug to treat poor performance non-small cell lung cancer unfit for standard platinum chemotherapy (IPSOS), and hydroxychloroquine for small cell lung cancer (Study 15).

Speaking of the award, Professor Lee said: “I am honoured and humbled to receive this award. Thank you to the BTOG steering committee, CRUK and UCL Cancer Trials Centre, and everyone who has supported our NCRI trials over the last decades. There is still much work to be done, and let us continue to work together to bring hope to those affected by lung cancer.”

Professor Siow-Ming Lee is a Professor of Medical Oncology at University College London (UCL), and a Consultant Medical Oncologist at UCL Hospitals (UCLH). 

Further information

• Professor Siow Ming Lee academic profile
• Professor Siow Ming Lee clinical profile
• Cancer Research UK & UCL Cancer Trials Centre
• British Thoracic Oncology Group